After US, India has conducted most coronavirus tests: White House

More than 3.5 million have tested positive for the coronavirus and 138,000 died of it in the US, says spokesperson

Coronavirus, Covid
Healthcare workers collect swab samples from people residing at a slum area for COVID-19 testing in Mumbai on Saturday.
Press Trust of India Washington
3 min read Last Updated : Jul 17 2020 | 8:59 AM IST
India has conducted the second largest number of coronavirus tests (12 million) after the US (42 million), the White House has said, differing from rankings put out by a widely tracked website.

More than 3.5 million people have tested positive with the coronavirus and 138,000 died in the US. Globally, more than 13.6 million have tested positive and over 586,000 have died.

"With regard to (the coronavirus) testing, we've done more than 42 million tests. The second-highest number is 12 million from India. We're leading the world in testing," White House Press Secretary Kayleigh McEnany told reporters at a news conference on Thursday.

The White House was responding to questions related to the coronavirus pandemic in the US.

"We have done more than any country in the world on testing; there's no doubt about that -- 42 million tests. The country with the next highest number is India at 12 million," McEnany said.

Worldometers.info website said the US leads the world in tests, Brazil is second and India is in third place.


This record testing, she said, is in a very stark contrast than the previous administration.

CBS is reporting that in 2009 under Obama-Biden, the Centers for Disease Control and Prevention abruptly advised states to stop testing for the H1N1 flu and stopped counting individual cases, she said.
A health worker collects a swab sample from a woman for Covid-19 test, in Kolkata on Monday. Photo: ANI

Ron Klain, Vice President Biden's former Chief of Staff said this: It is purely a fortuity that (H1N1) isn't one of the great mass casualty events in American history. It had nothing to do with us doing anything right. This is former VP Biden's Chief of Staff. It just had to do with luck, she said.

Contrary to that, this President led the world in testing; led the world in ventilators -- redistributing ventilators for therapeutics; 13 vaccine candidates -- one going into phase three clinical trial. This response has been extraordinary and historic. We didn't pause testing; the Obama-Biden administration did, and that was a shameful decision, McEnany said.

There has been encouraging news on vaccines, the press secretary said.

Moderna's vaccine candidate is showing promising signs. They produced a positive, neutral immune response among the 45 participants in the study. This is comparable to what we see in recovered patients. The bottom line is that, so far, we are seeing exactly what you would hope to see in a vaccine. The Moderna vaccine in particular is expected to reach phase three by late July, with 30,000 participants.

On the therapeutics front, I just want to note: A very encouraging Regeneron contract. A USD 450 million contract for a monoclonal antibody cocktail. This is a bioengineered version of convalescent plasma, one of the several therapeutics available to treat Covid-19. It can be used for prophylaxis and treatment. They say they could have up to 70 to 300 thousand doses -- by the end of the summer or early fall, she said.

As such there is encouraging news on the therapeutics front, McEnany added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineHealth Ministry

Next Story